Accéder au contenu
Merck

Comparative studies of doxorubicin and 4'-epidoxorubicin effects on cardiovascular system in rabbits.

Polish journal of pharmacology and pharmacy (1989-11-01)
A Fronczak, J Drzewoski, P Polakowski
RÉSUMÉ

4'-epidoxorubicin (4'-epiDXR) was compared with doxorubicin (DXR) for myocardial effects in rabbits. Histologically, both drugs when given for six weeks induced a high incidence of diffused myocardial damage. The myocardial damage was less evident in rabbits treated with 4'-epiDXR than DXR for 3 weeks. Functionally 4'-epiDXR like DXR significantly reduced cardiac index (CI), stroke index (SI) and mean arterial blood pressure (MAP).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Deslanoside, European Pharmacopoeia (EP) Reference Standard